InvestorsHub Logo
Followers 7
Posts 578
Boards Moderated 0
Alias Born 08/29/2014

Re: Rdunn88 post# 172828

Tuesday, 02/21/2017 10:56:59 PM

Tuesday, February 21, 2017 10:56:59 PM

Post# of 403504
$25 million to $50 million upfront is peanuts for a Pfizer interest in Prurisol, even with milestones along the way. Pfizer paid $5.2 billion for Anacor Pharmaceuticals having $99 million in yearly revenue. The crown jewel was Anacor's Crisabarole which may do $2 billion in revenues by 2022.

Tell me what risk Pfizer is taking on if Phase 2B Prurisol results are duplicated as 2A results?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News